Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
AOC 1020 Phase 2 Results Expected
AOC 1020 • FSHD
Target Indication
FSHD
Clinical Trial
Last updated: 12/4/2025
RNA
Avidity Biosciences, Inc.